Simplex Trading’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Simplex Trading’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-300	Closed	-$1K	–	11752
2021 Q4	$1K	Sell	300 -2,700	-90%	-$13.7K	﹤0.01%	10306
2021 Q3	$20K	Hold	3,000	–	–	﹤0.01%	8459
2021 Q2	$21K	Buy	+3,000	New	+$16.2K	﹤0.01%	8564

Simplex Trading's STSA Position: Q2 2023 in Review

Simplex Trading sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q2 2023, closing a stake of 21,864 shares — an estimated $15K sold.

Simplex Trading first reported a position in STSA in Q4 2021 and held it in 5 quarters. The position peaked at $406K in Q3 2022. 0 funds tracked by Wall St. Rank hold STSA as of Q2 2023.

Simplex Trading reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Simplex Trading sold 21,864 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $15K.
Simplex Trading first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
Simplex Trading's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $406K in Q3 2022.
0 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.